The Human Papillomavirus Vaccine Expanded to Middle Age Adults
There is a vaccine that can prevent persistent infection with the human papillomavirus (HPV), the etiological agent in many HPV-related cancers worldwide and within the United States. Globally, approximately 570,000 females and 60,000 males are diagnosed annually with a cancer that is related to the HPV.1 More than 90% of all cases of cervical and anal cancers are caused by persistent infection with the HPV, and it causes 75% of all cases of vaginal cancer, 70% of all cases of oropharyngeal and vulvar cancer, and 60% of penile cancer.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Denise Linton, Staci Taylor Tags: Quality Care for Women ’s Health Source Type: research
More News: Anal Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Nurses | Nursing | Oropharyngeal Cancer | Penile Cancer | USA Health | Vaccines | Vaginal Cancer | Vulvar Cancer | Women